Staphylococcus aureus (n=157) isolated from intramammary infections in Argentine dairy areas were evaluated for presence of cap5 and cap8 loci. Isolates carrying cap5 and cap8 were serotyped using specific antisera. Sixty four percent of the isolates were genotyped as cap5 or cap8 and 50% of them expressed CP5 or 8.
protective effect since they can opsonize encapsulated S. aureus from bovine origin for phagocytic killing by PMN (5).
The existence of 11 CP serotypes has been proposed (13) ; however, only four types (CP1, CP2, CP5 and CP8) have been chemically characterized. Among them, CP5 and CP8 are the predominant serotypes in S. aureus isolated from human and bovine infections (13) . Distribution of CP serotypes among S. aureus isolates from bovine milk from different countries shows variability (6, 15, 23) . A study carried out in Argentina found that only 14% from 195 S. aureus isolates were typeable by serological methods (21) . However, more than 70% of those isolates belonged to one province and only 9 isolates came from two provinces that concentrate about 60% of Argentina dairy production.
Capsular polysaccharides in vitro expression does not
necessarily correlate with expression under in vivo conditions (11, 13) . Therefore, surveys of CP prevalence taking into account only the in vitro phenotype, could underestimate the true distribution of virulent CP strains among a bacterial population. Up to now, the reports of CP prevalence have been mainly performed by in vitro phenotype analysis and only in few studies involving S. aureus from bovine origin, a subset of phenotyped isolates was typed by genetic methodology (21, 23) .
Protection afforded by antibodies against CPs is related to their prevalence and type distribution in the population of isolates present in different regions (10) . Therefore, the latter and/or changes in the appearance of milk; while subclinical IMI was defined as absence of clinical signs but somatic cell counts > 200,000 cells/ml.
Genomic DNA was extracted from each isolate with a standard phenol-chloroform procedure (14) . The presence of cap5k and cap8I loci was evaluated in all the isolates by Polymerase Chain Reaction (PCR). PCR was performed using genomic DNA as a template in a total volume of 25µl containing: 1x PCR buffer, 2mM MgCl2, 0.25 mM dNTPs Bacterial suspensions for preparation of typing sera were made from cultures of prototype S. aureus strains CP5 (Reynolds) and CP8 (Becker). These strains were isolated in 1979 from blood cultures at Kaiser permanent Hospital, North Hollywood, California (9) and were a kind gift from Dr. B.
Poutrel (INRA, Nouzilly, France). Bacteria were grown on Columbia agar (Britania, Buenos Aires) supplemented with 2.5% NaCl, harvested and inactivated following previously described conditions (8) . Two New Zealand white rabbits weighing 3 kg were immunized with each bacterial prototype according to the scheme described by Karakawa et al. (8, 12) .
Each rabbit serum was absorbed with S. aureus strain 57, to remove antibodies to noncapsular antigens as previously described (8) , aliquoted and stored at -70°C. CP from prototype strains 5 and 8 and all isolates typed by genetic method (n=101) were isolated as described by Fattom et al. (3) . Sixty four percent of the isolates were typeable by PCR with specific primers for loci cap5 or cap8; being the rest of the isolates nontypeable (NT). Eighty three (52.87%) isolates were genotyped as cap5 whereas eighteen (11.4%) as cap8.
None of the isolates positive for either cap5 or cap8 genes was found to amplify both genes, confirming specificity of PCR used. Distribution of genotypes among isolates originated in different geographical areas is shown in Table 1 (4, 7) ; however associations in these latter cases were established with patterns including several rather than individual genes (4).
Presence of CP alone is considered to be insufficient to generate a protective immune response; however, their inclusion in a multicomponent vaccine would be useful to improve control of S. aureus IMI (18, 19, 22) . In addition, relevance of CP as candidates for generating protective responses is underscored by the fact that a commercial vaccine currently available for S. aureus mastitis control contains capsulated strains expressing 3 serotypes of CP present among the population of bovine isolates in USA (10) . Sixty four percent of the isolates evaluated in this study carried cap5 and cap8 genes, which emphasizes the importance of including these components for rational design of mastitis vaccines.
